NRC — NRC HEALTH
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 70487 ·
Last close
$18.79
Market Cap
$423.46M
52W High
$21.48
52W Low
$14.71
ADV30
147,897
Next earnings
2026-07-27
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | — | — | — | — | — | — | — |
| Dec 2025 | 35,194,000 | 21,259,000 | 4,669,000 | 1,798,000 | 134,878,000 | 4,139,000 | 120,888,000 |
| Sep 2025 | 34,608,000 | 22,204,000 | 7,738,000 | 4,122,000 | 135,719,000 | 2,219,000 | 121,405,000 |
| Jun 2025 | 34,038,000 | 21,064,000 | 1,588,000 | -106,000 | 141,387,000 | 5,274,000 | 120,059,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$26,450,000
Investing CF
$-10,706,000
Financing CF
$-15,838,000
CapEx
$-10,706,000
Dividends Paid
$-10,978,000
Buybacks
$-20,180,000
EPS Diluted TTM
$0.39
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-17,298,000
Inventory
—
Receivables
$11,636,000
ST Investments
—
EBIT TTM
$22,606,000
Pretax Income TTM
$17,846,000
Interest Exp TTM
$4,760,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$138,642,000
EBITDA
$34,602,000
Free Cash Flow
$19,732,250
Enterprise Value
$498,949,504
Total Cash
$2,547,000
Total Debt
$78,032,000
Shares Out
22,536,696
Trailing EPS
$0.39
Book Value
$0.60
ROE
41.9%
ROA
12.2%
Div Yield
3.19%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 137,390,000 | 22,590,000 | 11,600,000 | 134,878,000 | 120,888,000 | — | 26,450,000 |
| Dec 2024 | 143,060,000 | 35,194,000 | 24,783,000 | 132,539,000 | 101,255,000 | — | 34,625,000 |
| Dec 2023 | 148,580,000 | 40,045,000 | 30,971,000 | 122,437,000 | 73,482,000 | — | 38,113,000 |
| Dec 2022 | 151,568,000 | 46,543,000 | 31,800,000 | 130,461,000 | 58,428,000 | — | 36,265,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$1.16
Max Pain — expiry 2026-06-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $10.00 · spot: $18.31 · call volume: 138 · put volume: 18
Expected Move to 2026-06-18:
±$0.95
(5.19%) —
implied range
$17.36 –
$19.26
· ATM straddle on $17.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MYGN | MYRIAD GENETICS INC | $408.96M | $4.33 | — |
| OABI | OmniAb, Inc. | $329.09M | $2.27 | — |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | $566.68M | $5.52 | — |
| NNNN | Anbio Biotechnology | $684.26M | $15.59 | — |
| TKNO | Alpha Teknova, Inc. | $225.18M | $4.20 | — |
News headlines (Yahoo Finance, 1h cache)
NRC Health and Healthcare Experience Foundation Launch Strategic Partnership to Deepen Support for Improving Experience, Safety, and Workforce Engagement
2026-06-09 13:00 · Yahoo
The Governance Institute Announces Blue Ribbon Committee on Health System Governance
2026-05-28 13:01 · Yahoo
NRC Health Brings Ambient Listening With Agentic AI to the Front Lines of Leader Rounding
2026-05-19 13:01 · Yahoo
There May Be Reason For Hope In NRC Health's (NASDAQ:NRC) Disappointing Earnings
2026-05-13 10:20 · Yahoo
NRC Health's Q1 Earnings Fall Y/Y Due to Elevated Operating Costs
2026-05-01 14:00 · Yahoo
NRC Health (NRC) Q1 2026 Earnings Call Highlights: Record TRCV and Landmark Deals Propel Growth
2026-04-29 07:10 · Yahoo
National Research Q1 Earnings Call Highlights
2026-04-28 23:39 · Yahoo
NRC Health Announces First Quarter 2026 Results
2026-04-28 20:00 · Yahoo
The Governance Institute Releases Falling Behind Report, Warning Health System Operations Are Advancing Faster than Governance
2026-04-27 15:59 · Yahoo
NRC Health Surges 62% in a Year: Should You Buy the Stock?
2026-04-15 17:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.